|
Initial Colonization Site:
|
Extra-GI (N = 50)
|
GI (N = 63)
|
Cochran-Mantel-Haenszel
|
|---|
|
Final Colonization Site
|
Organism
|
Probiotic (N = 18) n (%)
|
Placebo (N = 32) n (%)
|
P-value
|
Probiotic (N = 34) n (%)
|
Placebo (N = 29) n (%)
|
P-value
|
Odds Ratio
|
95% Confidence Interval
|
|
GI
|
MRSA
|
1 (5.6)
|
2 (6.3)
|
1.0000
|
5 (14.7)
|
4 (13.8)
|
1.0000
|
1.00
|
0.29–3.43
|
|
MSSA
|
9 (50.0)
|
16 (50.0)
|
0.8368
|
23 (67.7)
|
21 (72.4)
|
0.9105
|
0.78
|
0.34–1.83
|
|
SA Total
|
9 (50.0)
|
17 (53.1)
|
0.7588
|
25 (73.5)
|
24 (82.8)
|
0.7574
|
0.62
|
0.26–1.52
|
|
Extra-GI
|
MRSA
|
3 (16.7)
|
3 (9.4)
|
0.4485
|
5 (14.7)
|
4 (13.8)
|
1.0000
|
1.30
|
0.43–3.90
|
|
MSSA
|
15 (83.3)
|
19 (59.4)
|
0.1332
|
16 (47.1)
|
16 (55.2)
|
0.8635
|
1.11
|
0.49–2.53
|
|
SA Total
|
16 (88.9)
|
22 (68.8)
|
0.2728
|
20 (58.8)
|
19 (65.5)
|
0.6134
|
1.08
|
0.46–2.52
|
- Abbreviations: MRSA methicillin-resistant Staphylococcus aureus, MSSA methicillin susceptible Staphylococcus aureus, SA Staphylococcus aureus, GI gastrointestinal
